VerifiedEvidence: highv1.0.0

Intangible Cost

A cost representing the non-financial burden of illness or treatment, such as pain or reduced quality of life, that is hard to value in money.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept


Theoretically, Cost-Offset Analysis is an economic evaluation approach that quantifies the extent to which the additional costs of a healthcare intervention are compensated by reductions in other healthcare expenditures. The concept is based on the principle that more effective interventions may generate downstream savings by preventing disease progression, reducing complications, avoiding hospitalisations or decreasing the need for subsequent healthcare services. Cost-offset analysis is commonly incorporated within cost analyses, budget impact analyses and cost-effectiveness evaluations rather than being a standalone economic evaluation framework.

Mathematically, cost-offset analysis compares the incremental costs of an intervention with the healthcare costs avoided because of improved clinical outcomes. The net financial effect is determined by subtracting cost offsets from additional intervention costs. Although the concept has a straightforward mathematical representation, estimation of cost offsets typically requires decision models or observational analyses that project changes in healthcare resource utilisation over time.

In practice, cost offsets are estimated using clinical trial data, real-world evidence, epidemiological models or decision-analytic models that quantify reductions in healthcare utilisation. Typical cost offsets include avoided hospital admissions, emergency department visits, outpatient consultations, diagnostic tests and treatment of adverse events. Cost-offset analysis supports reimbursement decisions by demonstrating whether higher acquisition costs are partially or fully compensated by downstream savings.


Purpose


Used to estimate the extent to which additional expenditure on a healthcare intervention is offset by reductions in subsequent healthcare costs, thereby informing affordability and economic value.


Mathematical Formulae

Primary Formula

Net Cost = Incremental Intervention Cost ? Cost Offsets

Supporting Formulae

Cost Offsets = ?(Avoided Resource Use ? Unit Cost)

Net Savings = Cost Offsets ? Incremental Intervention Cost

If Net Savings > 0, the intervention produces an overall reduction in healthcare expenditure.

Related Mathematical Methods

  • Cost Analysis
  • Budget Impact Analysis
  • Net Budget Impact
  • Cost-Effectiveness Analysis
  • Incremental Cost Analysis
  • Decision-Analytic Modelling

Example


A new heart failure medicine increases annual drug expenditure by �2,400 per patient but reduces hospital admissions by an average of 0.30 admissions per patient annually. Each avoided admission costs �5,000.

Cost Offset = 0.30 ? �5,000 = �1,500

Net Cost = �2,400 ? �1,500 = �900

Although the medicine costs more to purchase, reduced hospitalisations offset 62.5% of the additional treatment cost.


Excel Implementation

FunctionExample FormulaHealth Economics Application
SUMPRODUCT=SUMPRODUCT(AvoidedEventsRange,UnitCostRange)Calculates total healthcare cost offsets.
SUM=SUM(OffsetRange)Aggregates savings across multiple healthcare resources.
IF=IF(OffsetCost>IncrementalCost,"Cost Saving","Additional Cost")Classifies the financial consequence of the intervention.
XLOOKUP=XLOOKUP(Resource,ResourceList,UnitCostList)Retrieves unit costs for avoided healthcare resources.
LET=LET(IC,B2,CO,C2,IC-CO)Calculates net cost after accounting for cost offsets.

VBA (Optional)


VBA can automate calculation of cost offsets across multiple healthcare resource categories and generate scenario analyses for alternative treatment uptake assumptions.


Sources

  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press.
  • Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford University Press.
  • NICE. Health Technology Evaluation Manual.
  • ISPOR Good Practice Reports for Budget Impact Analysis and Economic Evaluation.

Library

Publications

2
  • BookFeatured

    Methods for the Economic Evaluation of Health Care Programmes — Drummond, Sculpher, Claxton, Stoddart & Torrance, 4th Edition ed., 2015 (Oxford University Press)

    The standard international reference text for economic evaluation methods in health care, covering cost-effectiveness, cost-utility and cost-benefit analysis, measurement of costs and outcomes, evidence synthesis, and the characterisation of uncertainty.

  • Book

    Economic Analysis in Health Care — Morris, Devlin, Parkin & Spencer, 2nd Edition ed., 2012 (John Wiley & Sons)

    A core textbook for advanced undergraduate and postgraduate health economics students, covering both the economics of health care systems and the evaluation of health care technologies, with international case studies and a strong balance of theory and application.

Frequently Asked Questions (6)

  • What is an intangible cost?

    A cost representing the non-financial burden of illness or treatment, such as pain or reduced quality of life, that is hard to value in money.

    Source: Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015.

  • What does intangible cost cover?

    It covers the burden of illness and treatment that is genuinely borne but is not a payment or a use of measurable resources: pain, distress, anxiety, restricted activity, the loss of independence, and the effect on how a person experiences their life. These are consequences of the condition rather than expenditures on it, and they were originally grouped as a third category alongside direct and productivity costs because early frameworks had no other place for them.

    Source: Drummond et al. 2015

  • Why is intangible cost treated differently now?

    Because preference-based measures of health capture much of it directly. When people value a health state described in terms of pain, mobility and mood, they are valuing exactly the burden this category describes, and that valuation already enters the analysis through the health outcome. Adding a separate monetary figure for pain and suffering alongside a quality-adjusted outcome therefore counts the same consequence twice, which is why most current frameworks do not treat intangibles as a separate cost.

    Source: Drummond et al. 2015

  • What intangible cost is not captured by health outcome measures?

    Effects falling on people other than the patient are largely absent, since standard measures describe the patient's own state and carers' distress and disruption are not counted anywhere. Aspects of the experience of care rather than of health, including dignity, the burden of attending and the anxiety of waiting, are also outside most instruments. Where these matter to the decision, they belong in the analysis as stated considerations rather than as an omitted cost category.

    Source: healtheconomics.wiki

  • Can intangible cost be valued in money?

    They can, through stated preference methods asking what people would pay to avoid a described experience, and such values are used in sectors where a monetary framework is required. The estimates are wide, sensitive to how the scenario is put, and bounded by ability to pay. The practical position in health economics is that valuing these consequences in health units is more defensible than valuing them in money, which is one reason cost-effectiveness rather than cost-benefit analysis predominates.

    Source: Mitchell & Carson 1989

  • How should an analysis handle intangible cost?

    The safest treatment is to state where they have been captured, which for the patient's own experience is normally within the health outcome measure, and to identify explicitly any that fall outside it. Where an important consequence is neither in the outcome measure nor in the costs, describing it qualitatively alongside the results is more honest than omitting it or than inserting a monetary figure that would double count. Silence is the option that misleads.

    Source: healtheconomics.wiki

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 29 Jul 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EE-CA-054

Stable URI · Machine-readable · Resolvable · CC BY 4.0